At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label Clinical Trial Conducted Via Telepsychiatry of Complementary and Alternative Treatments (Omega-3 Fatty Acids and Inositol vs. N-acetylcysteine) for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)
In Brief
A Phase 4 clinical trial evaluating Open-label Treatment with Omega-3 Fatty Acids + Inositol and Open-label Treatment with N-acetylcysteine for Non-verbal Learning Disorder and 2 related conditions. Completed, enrolled 54 participants across 1 site.
Detailed Summary
This study consists of a 6-week, open-label, randomized clinical trial study to compare efficacy and tolerability of the natural treatments omega-3 fatty acids, inositol, and N-acetylcysteine (NAC) in the treatment of mood dysregulation in children and adolescents with non-verbal learning disability (NVLD) or Autism Spectrum Disorder (ASD). Subjects will include youth ages 5-17 years with a non-verbal learning disability (NVLD) or autism spectrum disorder (ASD) and current symptoms of emotional dysregulation.
Study Details
Timeline
Interventions
Open-label Treatment with Omega-3 Fatty Acids + Inositol
Open-label Treatment with acetylcysteine